Please login to the form below

Q2 results

This page shows the latest Q2 results news and features for those working in and with pharma, biotech and healthcare.

Bristol-Myers Squibb’s revenues rise on Celgene acquisition

The positive quarterly results build on BMS’ key patent challenge victory on Wednesday for its blood thinner Eliquis (apixaban). ... One concerning caveat among the otherwise positive results was the decrease in sales for BMS’ immunotherapy Opdivo,

Latest news

Gilead’s top-line slips 10% as demand for HIV/hepatitis C drugs drops

Disruption to uptake of HIV and hepatitis C drugs caused by pandemic
AstraZeneca escapes pandemic impact as new drugs bolster revenues

That includes a rise in product sales, with a 6% increase in Q2 to $6.04bn and an 11% increase to $12.36bn for the half year. ... The pharma giant seems to have avoided any significant effects on its earnings in the quarter, compared to other drugmakers
Roche cites COVID-19 and biosimilars in Q2 decline

Pharmaceutical sales took a 4% hit in Swiss francs. Swiss pharma Roche is the latest pharma company to be hit in its second quarter results by the COVID-19 pandemic, with ... Roche’s diagnostic division results were a mixed bag, with overall sales
Biogen raises full year guidance after beating Q2 expectations

Prior to the results presentation, investors were rocked by the unexpected news that Biogen’s chief financial officer Jeffrey Capello was departing from the company. ... Biogen completed a marketing application for the high-risk Alzheimer’s therapy
Novartis stumbles in Q2 as COVID-19 impacts sales

The company reported that net income was down 11% to $1.9bn compared with last year’s second quarter results. ... Despite the somewhat marred results, there were some highlights in the Q2 results, including a strong launch for the company’s spinal

More from news
Approximately 13 fully matching, plus 25 partially matching documents found.

Latest Intelligence

Interview: Joseph Jimenez, Novartis

Our broad, yet focused, portfolio delivered strong results in Q2, with sales growing 19 per cent. ... Consumer health grew five per cent in Q2, largely due to products like Theraflu and Voltaren.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping: Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much: Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website: You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...